Cargando…

Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage

Insulin resistance leads to excessive endothelial cell (EC) superoxide generation and accelerated atherosclerosis. The principal source of superoxide from the insulin-resistant endothelium is the Nox2 isoform of NADPH oxidase. Here we examine the therapeutic potential of Nox2 inhibition on superoxid...

Descripción completa

Detalles Bibliográficos
Autores principales: Maqbool, Azhar, Watt, Nicole T., Haywood, Natalie, Viswambharan, Hema, Skromna, Anna, Makava, Natalia, Visnagri, Asjad, Shawer, Heba M., Bridge, Katherine, Muminov, Shovkat K., Griffin, Kathryn, Beech, David J., Wheatcroft, Stephen B., Porter, Karen E., Simmons, Katie J., Sukumar, Piruthivi, Shah, Ajay M., Cubbon, Richard M., Kearney, Mark T., Yuldasheva, Nadira Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Physiological Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468885/
https://www.ncbi.nlm.nih.gov/pubmed/32401607
http://dx.doi.org/10.1152/ajpcell.00389.2019
_version_ 1783578309637963776
author Maqbool, Azhar
Watt, Nicole T.
Haywood, Natalie
Viswambharan, Hema
Skromna, Anna
Makava, Natalia
Visnagri, Asjad
Shawer, Heba M.
Bridge, Katherine
Muminov, Shovkat K.
Griffin, Kathryn
Beech, David J.
Wheatcroft, Stephen B.
Porter, Karen E.
Simmons, Katie J.
Sukumar, Piruthivi
Shah, Ajay M.
Cubbon, Richard M.
Kearney, Mark T.
Yuldasheva, Nadira Y.
author_facet Maqbool, Azhar
Watt, Nicole T.
Haywood, Natalie
Viswambharan, Hema
Skromna, Anna
Makava, Natalia
Visnagri, Asjad
Shawer, Heba M.
Bridge, Katherine
Muminov, Shovkat K.
Griffin, Kathryn
Beech, David J.
Wheatcroft, Stephen B.
Porter, Karen E.
Simmons, Katie J.
Sukumar, Piruthivi
Shah, Ajay M.
Cubbon, Richard M.
Kearney, Mark T.
Yuldasheva, Nadira Y.
author_sort Maqbool, Azhar
collection PubMed
description Insulin resistance leads to excessive endothelial cell (EC) superoxide generation and accelerated atherosclerosis. The principal source of superoxide from the insulin-resistant endothelium is the Nox2 isoform of NADPH oxidase. Here we examine the therapeutic potential of Nox2 inhibition on superoxide generation in saphenous vein ECs (SVECs) from patients with advanced atherosclerosis and type 2 diabetes and on vascular function, vascular damage, and lipid deposition in apolipoprotein E-deficient (ApoE(−/−)) mice with EC-specific insulin resistance (ESMIRO). To examine the effect of genetic inhibition of Nox2, ESMIRO mice deficient in ApoE(−/−) and Nox2 (ESMIRO/ApoE(−/−)/Nox2(−/y)) were generated and compared with ESMIRO/ApoE(−/−)/Nox2(+/y) littermates. To examine the effect of pharmacological inhibition of Nox2, we administered gp91dstat or scrambled peptide to ESMIRO/ApoE(−/−) mice. SVECs from diabetic patients had increased expression of Nox2 protein with concomitant increase in superoxide generation, which could be reduced by the Nox2 inhibitor gp91dstat. After 12 wk Western diet, ESMIRO/ApoE(−/−)/Nox2(−/y) mice had reduced EC superoxide generation and greater aortic relaxation to acetylcholine. ESMIRO/ApoE(−/−)/Nox2(−/y) mice developed more lipid deposition in the thoraco-abdominal aorta with multiple foci of elastin fragmentation at the level of the aortic sinus and greater expression of intercellular adhesion molecule-1 (ICAM-1). Gp91dstat reduced EC superoxide and lipid deposition in the thoraco-abdominal aorta of ESMIRO/ApoE(−/−) mice without causing elastin fragmentation or increased ICAM-1 expression. These results demonstrate that insulin resistance is characterized by increased Nox2-derived vascular superoxide. Complete deletion of Nox2 in mice with EC insulin resistance exacerbates, whereas partial pharmacological Nox2 inhibition protects against, insulin resistance-induced vascular damage.
format Online
Article
Text
id pubmed-7468885
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Physiological Society
record_format MEDLINE/PubMed
spelling pubmed-74688852020-09-14 Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage Maqbool, Azhar Watt, Nicole T. Haywood, Natalie Viswambharan, Hema Skromna, Anna Makava, Natalia Visnagri, Asjad Shawer, Heba M. Bridge, Katherine Muminov, Shovkat K. Griffin, Kathryn Beech, David J. Wheatcroft, Stephen B. Porter, Karen E. Simmons, Katie J. Sukumar, Piruthivi Shah, Ajay M. Cubbon, Richard M. Kearney, Mark T. Yuldasheva, Nadira Y. Am J Physiol Cell Physiol Research Article Insulin resistance leads to excessive endothelial cell (EC) superoxide generation and accelerated atherosclerosis. The principal source of superoxide from the insulin-resistant endothelium is the Nox2 isoform of NADPH oxidase. Here we examine the therapeutic potential of Nox2 inhibition on superoxide generation in saphenous vein ECs (SVECs) from patients with advanced atherosclerosis and type 2 diabetes and on vascular function, vascular damage, and lipid deposition in apolipoprotein E-deficient (ApoE(−/−)) mice with EC-specific insulin resistance (ESMIRO). To examine the effect of genetic inhibition of Nox2, ESMIRO mice deficient in ApoE(−/−) and Nox2 (ESMIRO/ApoE(−/−)/Nox2(−/y)) were generated and compared with ESMIRO/ApoE(−/−)/Nox2(+/y) littermates. To examine the effect of pharmacological inhibition of Nox2, we administered gp91dstat or scrambled peptide to ESMIRO/ApoE(−/−) mice. SVECs from diabetic patients had increased expression of Nox2 protein with concomitant increase in superoxide generation, which could be reduced by the Nox2 inhibitor gp91dstat. After 12 wk Western diet, ESMIRO/ApoE(−/−)/Nox2(−/y) mice had reduced EC superoxide generation and greater aortic relaxation to acetylcholine. ESMIRO/ApoE(−/−)/Nox2(−/y) mice developed more lipid deposition in the thoraco-abdominal aorta with multiple foci of elastin fragmentation at the level of the aortic sinus and greater expression of intercellular adhesion molecule-1 (ICAM-1). Gp91dstat reduced EC superoxide and lipid deposition in the thoraco-abdominal aorta of ESMIRO/ApoE(−/−) mice without causing elastin fragmentation or increased ICAM-1 expression. These results demonstrate that insulin resistance is characterized by increased Nox2-derived vascular superoxide. Complete deletion of Nox2 in mice with EC insulin resistance exacerbates, whereas partial pharmacological Nox2 inhibition protects against, insulin resistance-induced vascular damage. American Physiological Society 2020-07-01 2020-05-13 /pmc/articles/PMC7468885/ /pubmed/32401607 http://dx.doi.org/10.1152/ajpcell.00389.2019 Text en Copyright © 2020 the American Physiological Society http://creativecommons.org/licenses/by/4.0/deed.en_US Licensed under Creative Commons Attribution CC-BY 4.0 (http://creativecommons.org/licenses/by/4.0/deed.en_US) : © the American Physiological Society.
spellingShingle Research Article
Maqbool, Azhar
Watt, Nicole T.
Haywood, Natalie
Viswambharan, Hema
Skromna, Anna
Makava, Natalia
Visnagri, Asjad
Shawer, Heba M.
Bridge, Katherine
Muminov, Shovkat K.
Griffin, Kathryn
Beech, David J.
Wheatcroft, Stephen B.
Porter, Karen E.
Simmons, Katie J.
Sukumar, Piruthivi
Shah, Ajay M.
Cubbon, Richard M.
Kearney, Mark T.
Yuldasheva, Nadira Y.
Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage
title Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage
title_full Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage
title_fullStr Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage
title_full_unstemmed Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage
title_short Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage
title_sort divergent effects of genetic and pharmacological inhibition of nox2 nadph oxidase on insulin resistance-related vascular damage
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468885/
https://www.ncbi.nlm.nih.gov/pubmed/32401607
http://dx.doi.org/10.1152/ajpcell.00389.2019
work_keys_str_mv AT maqboolazhar divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT wattnicolet divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT haywoodnatalie divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT viswambharanhema divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT skromnaanna divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT makavanatalia divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT visnagriasjad divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT shawerhebam divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT bridgekatherine divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT muminovshovkatk divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT griffinkathryn divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT beechdavidj divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT wheatcroftstephenb divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT porterkarene divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT simmonskatiej divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT sukumarpiruthivi divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT shahajaym divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT cubbonrichardm divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT kearneymarkt divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage
AT yuldashevanadiray divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage